27726295|t|Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis
27726295|a|In Chile, where gallbladder cancer (GBC) rates are high and typhoid fever was endemic until the 1990s, we evaluated the association between Salmonella enterica serovar Typhi (S. Typhi) antibodies and GBC. We tested 39 GBC cases, 40 gallstone controls, and 39 population-based controls for S. Typhi Vi antibodies and performed culture and quantitative polymerase chain reaction for the subset with bile, gallstone, tissue, and stool samples available. We calculated gender and education-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the association with GBC. We also conducted a meta-analysis of >1000 GBC cases by combining our results with previous studies. GBC cases were more likely to have high Vi antibody titer levels than combined controls (OR: 4.0, 95% CI: 0.9-18.3), although S. Typhi was not recovered from bile, gallstone, tissue, or stool samples. In our meta-analysis, the summary relative risk was 4.6 (95% CI: 3.1-6.8, P heterogeneity =0.6) for anti-Vi and 5.0 (95% CI: 2.7-9.3, P heterogeneity = 0.2) for bile or stool culture. Our results are consistent with the meta-analysis. Despite differences in study methods (e.g., S. Typhi detection assay), most studies found a positive association between S. Typhi and GBC. However, the mechanism underlying this association requires further investigation.
27726295	0	33	Salmonella enterica serovar Typhi	T007	UMLS:C0036125
27726295	38	56	gallbladder cancer	T038	UMLS:C0153452
27726295	60	78	case-control study	T062	UMLS:C0007328
27726295	83	96	meta-analysis	T062	UMLS:C0920317
27726295	100	106	Chile,	T082	UMLS:C0008107
27726295	113	131	gallbladder cancer	T038	UMLS:C0153452
27726295	133	136	GBC	T038	UMLS:C0153452
27726295	157	170	typhoid fever	T038	UMLS:C0041466
27726295	203	212	evaluated	T058	UMLS:C0220825
27726295	237	270	Salmonella enterica serovar Typhi	T007	UMLS:C0036125
27726295	272	280	S. Typhi	T007	UMLS:C0036125
27726295	282	292	antibodies	T103	UMLS:C0003241
27726295	297	300	GBC	T038	UMLS:C0153452
27726295	315	318	GBC	T038	UMLS:C0153452
27726295	329	338	gallstone	T031	UMLS:C0242216
27726295	386	408	S. Typhi Vi antibodies	T103	UMLS:C0443684
27726295	435	473	quantitative polymerase chain reaction	T062	UMLS:C3179034
27726295	494	498	bile	T031	UMLS:C0005388
27726295	500	509	gallstone	T031	UMLS:C0242216
27726295	511	517	tissue	T017	UMLS:C0040300
27726295	523	536	stool samples	T031	UMLS:C1550661
27726295	670	673	GBC	T038	UMLS:C0153452
27726295	695	708	meta-analysis	T062	UMLS:C0920317
27726295	718	721	GBC	T038	UMLS:C0153452
27726295	776	779	GBC	T038	UMLS:C0153452
27726295	816	827	Vi antibody	T103	UMLS:C0443684
27726295	902	910	S. Typhi	T007	UMLS:C0036125
27726295	915	928	not recovered	T033	UMLS:C1709277
27726295	934	938	bile	T031	UMLS:C0005388
27726295	940	949	gallstone	T031	UMLS:C0242216
27726295	951	957	tissue	T017	UMLS:C0040300
27726295	962	975	stool samples	T031	UMLS:C1550661
27726295	984	997	meta-analysis	T062	UMLS:C0920317
27726295	1077	1084	anti-Vi	T103	UMLS:C0443684
27726295	1138	1142	bile	T031	UMLS:C0005388
27726295	1146	1159	stool culture	T058	UMLS:C0430414
27726295	1197	1210	meta-analysis	T062	UMLS:C0920317
27726295	1256	1264	S. Typhi	T007	UMLS:C0036125
27726295	1265	1280	detection assay	T058	UMLS:C0005507
27726295	1304	1312	positive	T033	UMLS:C1446409
27726295	1333	1341	S. Typhi	T007	UMLS:C0036125
27726295	1346	1349	GBC	T038	UMLS:C0153452